home / stock / achv / achv news


ACHV News and Press, Achieve Life Sciences Inc.

Stock Information

Company Name: Achieve Life Sciences Inc.
Stock Symbol: ACHV
Market: NASDAQ
Website: achievelifesciences.com

Menu

Get ACHV Alerts

News, Short Squeeze, Breakout and More Instantly...

ACHV - Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able

2026-07-07 11:33:38 ET Intro Since my last analysis about Achieve Life Sciences ( ACHV ) back in February 2026, much has happened. I rated the stock a “strong buy” back then, and shares, as expected, continued to advance, in this case about 50%.... Read t...

ACHV - Achieve Life Sciences Joins Russell 2000® Index

SEATTLE and VANCOUVER, British Columbia, June 29, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine depend...

ACHV - Achieve Life Sciences: CRL Is Fixable, So I Remain Bullish

2026-06-23 07:30:14 ET ... Read the full article on Seeking Alpha For further details see: Achieve Life Sciences: CRL Is Fixable, So I Remain Bullish

ACHV - Achieve Life Sciences jumps despite cytisinicline CRL

2026-06-22 11:24:05 ET More on Achieve Life Sciences Achieve Life Sciences: 'Hold' On Expected CRL Cytisinicline And Q4 2026 NDA Resubmission Achieve Life Sciences, Inc. (ACHV) Q1 2026 Earnings Call Transcript Achieve Life Sciences: The Recent Sell-Off Skews The Outc...

ACHV - Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

CRL Cites Deficiencies at Third-Party Manufacturing Facility No Efficacy or Clinical Safety Deficiencies Identified SEATTLE and VANCOUVER, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharma...

ACHV - Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

SEATTLE and VANCOUVER, British Columbia, June 02, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (“Achieve” or the “Company”) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as...

ACHV - Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment

ORCA-OL data complete the clinical evidence package supporting the cytisinicline smoking cessation NDA No new safety signals identified by the independent Data Safety Monitoring Committee over 52 weeks of continuous exposure Nausea — a common barrier to treatment adherence with smo...

ACHV - Achieve Life Sciences: 'Hold' On Expected CRL Cytisinicline And Q4 2026 NDA Resubmission

2026-05-13 15:17:34 ET The last time I spoke about Achieve Life Sciences ( ACHV ) it was with a Seeking Alpha article entitled " Achieve Life Sciences: Maintaining 'Buy' On Upcoming PDUFA And Expansion Into Vaping Cessation ." With respect to this article, I mentioned th...

ACHV - Achieve (ACHV) Q1 2026 Earnings Transcript

2026-05-12 12:56:21 ET Image source: The Motley Fool. Tuesday, May 12, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

ACHV - Achieve outlines Q4 2026 NDA resubmission and 1H 2027 launch plans following $180M financing

2026-05-12 11:42:48 ET More on Achieve Life Sciences Achieve Life Sciences, Inc. (ACHV) Q1 2026 Earnings Call Transcript Achieve Life Sciences: The Recent Sell-Off Skews The Outcomes Achieve Life Sciences: Maintaining 'Buy' On Upcoming PDUFA And Expansion Into Vaping...

Next 10